{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:12:39Z","timestamp":1769163159488,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"vor","delay-in-days":268,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rituximab (RTX) has become a standard therapy for certain B cell malignancies and autoimmune diseases. We report 2 RTX-treated patients who developed severe tick-borne encephalitis virus (TBEV) infection. The inability to generate new antibody responses renders RTX-treated patients susceptible to TBEV, impedes laboratory diagnosis, and necessitates preventive vaccination in endemic areas.<\/jats:p>","DOI":"10.1093\/ofid\/ofx204","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T13:15:41Z","timestamp":1506431741000},"source":"Crossref","is-referenced-by-count":21,"title":["Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention"],"prefix":"10.1093","volume":"4","author":[{"given":"Philipp A","family":"Steininger","sequence":"first","affiliation":[{"name":"Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Bobinger","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenke","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nuremberg Hospital South, Paracelsus Medizinische Privatuniversit\u00e4t (PMU), N\u00fcrnberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Hyung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Knott","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Korn","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Lang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"2020081005190977600_CIT0001","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"2020081005190977600_CIT0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-070912-133235","article-title":"Anti-B cell antibody therapies for inflammatory rheumatic diseases","volume":"65","author":"Faurschou","year":"2014","journal-title":"Annu Rev Med"},{"key":"2020081005190977600_CIT0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon Beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"2020081005190977600_CIT0004","first-page":"566","article-title":"Hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologics treatment","volume":"215","author":"Chen","year":"2017","journal-title":"J Infect Dis"},{"key":"2020081005190977600_CIT0005","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/cid\/ciu189","article-title":"Infections with the tick-borne bacterium \u201cCandidatus Neoehrlichia mikurensis\u201d mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases","volume":"58","author":"Grankvist","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081005190977600_CIT0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients","volume":"46","author":"Krause","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020081005190977600_CIT0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1386-6532(02)00168-3","article-title":"Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA","volume":"27","author":"Schwaiger","year":"2003","journal-title":"J Clin Virol"},{"key":"2020081005190977600_CIT0008","first-page":"855","article-title":"Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab","volume":"56","author":"Knight","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2020081005190977600_CIT0009","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3899\/jrheum.111513","article-title":"Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin \u03ba and \u03bb light chains","volume":"39","author":"Palanichamy","year":"2012","journal-title":"J Rheumatol"},{"key":"2020081005190977600_CIT0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcv.2015.05.019","article-title":"Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy","volume":"69","author":"Caracciolo","year":"2015","journal-title":"J Clin Virol"},{"key":"2020081005190977600_CIT0011","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/infdis\/jix040","article-title":"A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting","volume":"215","author":"Lipowski","year":"2017","journal-title":"J Infect Dis"},{"key":"2020081005190977600_CIT0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2334-13-306","article-title":"May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?","volume":"13","author":"R\u016f\u017eek","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2020081005190977600_CIT0013","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv136","article-title":"West Nile virus central nervous system infection in patients treated with rituximab: implications for diagnosis and prognosis, with a review of literature","volume":"2","author":"Morjaria","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2020081005190977600_CIT0014","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/CVI.05705-11","article-title":"Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations","volume":"19","author":"Rabel","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"2020081005190977600_CIT0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","article-title":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"34","author":"Hertzell","year":"2016","journal-title":"Vaccine"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/4\/ofx204\/33623858\/ofx204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/4\/ofx204\/33623858\/ofx204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:27:28Z","timestamp":1597051648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofx204\/4237570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofx204","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017]]},"published":{"date-parts":[[2017]]},"article-number":"ofx204"}}